|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred loan costs | |||||
| Write-off of other assets | |||||
| Loss on derivative instruments, net | |||||
| Gain on sale of assets, net | |||||
| Loss (gain) on extinguishment of debt | |||||
| Casualty impairments | |||||
| Long-lived asset impairment | |||||
| Gain on extinguishment of debt | |||||
| Loss from equity method investment | |||||
| Provision for credit losses | |||||
| Non-cash stock-based compensation expense | |||||
| Other non-cash items | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Other assets, net | |||||
| Accounts payable and accrued expenses | |||||
| Federal and state income taxes payable | |||||
| Deferred income | |||||
| Customer deposits | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Investments in unconsolidated entity | |||||
| Return of investment in unconsolidated entity | |||||
| Acquisition of new communities | |||||
| Capital expenditures | |||||
| Proceeds from sale of assets | |||||
| Net cash used in investing activities | |||||
| Financing Activities | |||||
| Proceeds from issuance of common stock, net of issuance costs | |||||
| Shares withheld for taxes | |||||
| Proceeds from notes payable | |||||
| Repayments of notes payable | |||||
| Proceeds from revolving credit facility | |||||
| Repayment of revolving credit facility | |||||
| Capital contributions from noncontrolling investors in joint ventures | |||||
| Distributions to noncontrolling investors in joint ventures | |||||
| Dividends paid on Series A convertible preferred stock | |||||
| Deferred loan costs paid | |||||
| Purchase of derivative assets | |||||
| Other financing costs | |||||
| Net cash provided by financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents and restricted cash at beginning of year | |||||
| Cash and cash equivalents and restricted cash at end of year | |||||
| Supplemental Disclosures | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes paid, net - Texas | |||||
| Non-cash investing and financing activities: | |||||
| Notes payable acquired through acquisitions | |||||
| Undeclared dividends on Series A convertible preferred stock | |||||
| Insurance financed through insurance notes payable | |||||
| Non-cash additions of property and equipment | |||||
| Non-cash right-of-use assets | |||||
Loading...